Home / NTRB : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does NTRB make money? Does NTRB have pricing power? What's the Earnings Whisper? Will NTRB profit more as the business scales? What is NTRB's management track record? Is NTRB's current price justified?

Nutriband Inc.

$6.96 +$2.53 (+57.11%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$6.08

Day Range

$6.09$6.97

Year Range

$2.8$8.63

Market Cap

84.61M

AVG Volume

22.03K

Trailing/Forward PE

-12.17/1.9

PEG ratio

-0.09

Dividend Yield

Next Earnings Date

2026-12-07

Primary Exchange

NASDAQ

Revenue (USD)

NTRB Revenue (USD) by year
Period	Revenue (USD)
2025	2.04M
2024	2.14M
2023	2.09M
2022	2.08M
2021	1.42M
2020	943.7K
2019	370.65K
2018	245.28K
2017	0
2016	0

Net Income (USD)

NTRB Net Income (USD) by year
Period	Net Income (USD)
2025	-8.23M
2024	-10.48M
2023	-5.49M
2022	-4.5M
2021	-6.18M
2020	-2.93M
2019	-2.72M
2018	-3.33M
2017	-2.67M
2016	-151.26K

Operating Income (USD)

NTRB Operating Income (USD) by year
Period	Operating Income (USD)
2025	-8.32M
2024	-6.69M
2023	-4.87M
2022	-4.48M
2021	-6.11M
2020	-2.6M
2019	-1.97M
2018	-3.33M
2017	-171.95K
2016	-151.26K

EBITDA (USD)

NTRB EBITDA (USD) by year
Period	EBITDA (USD)
2025	-8.01M
2024	-10.18M
2023	-5.11M
2022	-3.78M
2021	-5.74M
2020	-2.48M
2019	-2.56M
2018	-3.27M
2017	-109.45K
2016	-63.56K

Cash Flows (USD)

NTRB Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-5.13M
2024	-4.72M
2023	-3.58M
2022	-3.07M
2021	-2.89M
2020	-297.06K
2019	-894.47K
2018	-1.11M
2017	-92.86K
2016	-147.92K

EPS (USD)

NTRB EPS (USD) by year
Period	EPS (USD)
2025	-2.64
2024	-0.99
2023	-0.69
2022	-0.54
2021	-0.81
2020	-0.46
2019	-0.43
2018	-0.53
2017	-0.44
2016	-0.02

Expenses (USD)

NTRB Expenses (USD) by year
Period	Expenses (USD)
2025	8.88M
2024	7.48M
2023	5.77M
2022	4.98M
2021	4.52M
2020	2.96M
2019	1.79M
2018	3.29M
2017	171.95K
2016	151.26K

Cash & Debt (USD)

NTRB Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	4.57M
2024	4.31M
2023	492.94K
2022	1.99M
2021	4.89M
2020	151.99K
2019	10.18K
2018	474.65K
2017	0
2016	27.12K

Debt ratios

NTRB Debt ratios by year
Period	Debt ratios
2025	0.16
2024	0.17
2023	0.01
2022	0.12
2021	0.34
2020	-0.19
2019	-0.05

Margins

NTRB Margins by year
Period	Margins
2025	27.81%
2024	32.68%
2023	40.81%
2022	36.08%
2021	35.46%
2020	38.29%
2019	-48.15%
2018	-17.54%

Return on Capital

NTRB Return on Capital by year
Period	Return on Capital
2025	-123.21%
2024	-163.04%
2023	-85.2%
2022	-52.44%
2021	-52.08%
2020	-41.24%
2019	-1551.38%
2018	-138.54%
2017	-2198.99%
2016	-654.55%

Shares Outstanding

NTRB Shares Outstanding by year
Period	Shares Outstanding
2025	12.16M
2024	10.61M
2023	8.2M
2022	7.83M
2021	7.59M
2020	6.43M
2019	6.33M
2018	6.33M
2017	6.09M
2016	6.06M

Book Value Per Share (USD)

NTRB Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	0.55
2024	0.61
2023	0.79
2022	1.09
2021	1.56
2020	1.11
2019	0.03
2018	0.38
2017	0.02
2016	0

Total Assets (USD)

NTRB Total Assets (USD) by year
Period	Total Assets (USD)
2025	7.55M
2024	7.47M
2023	7.52M
2022	9.46M
2021	12.74M
2020	9.93M
2019	2.2M
2018	2.81M
2017	164.9K
2016	37.73K

Employee Count

NTRB Employee Count by year
Period	Employee Count
2026	500
2025	2.02K
2024	2.02K
2022	13
2021	13
2019	7
2018	150
2017	150

Free Cash Flow Yield

NTRB Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-4.29%
Sep 26	-5.01%
Aug 26	-8.03%
Aug 26	-7.67%
Aug 26	-10.86%
Aug 26	-11.52%
Jul 26	-12.57%
Jul 26	-12.02%
Jul 26	-11.52%
Jul 26	-12.1%
Jul 26	-11.71%
Jun 26	-11.71%
Jun 26	-12.36%
Jun 26	-10.57%
Jun 26	-11.79%
May 26	-12.09%
May 26	-11.59%
May 26	-11.72%
May 26	-11.25%
May 26	-10.93%
Apr 26	-11.69%
Apr 26	-10.87%
Apr 26	-11.99%
Apr 26	-12.88%
Mar 26	-12.11%
Mar 26	-12.67%
Mar 26	-12.53%
Mar 26	-10.72%
Feb 26	-10.53%
Feb 26	-10.55%
Feb 26	-11.37%
Feb 26	-10.75%
Jan 26	-9.76%
Jan 26	-9.74%
Jan 26	-10.72%
Jan 26	-10.7%
Jan 26	-10.55%
Dec 25	-9.74%
Dec 25	-10.41%
Dec 25	-9.17%
Dec 25	-9.14%
Nov 25	-8.9%
Nov 25	-9.21%
Nov 25	-8.01%
Nov 25	-7.3%
Oct 25	-6.54%
Oct 25	-6.16%
Oct 25	-5.89%
Oct 25	-5.86%
Oct 25	-5.93%
Sep 25	-6.07%
Sep 25	-6.1%
Sep 25	-6.16%
Sep 25	-7.35%
Aug 25	-7.25%
Aug 25	-7.28%
Aug 25	-7.14%
Aug 25	-6.54%
Aug 25	-6.34%
Jul 25	-5.5%
Jul 25	-5.78%
Jul 25	-5.89%
Jul 25	-4.73%
Jun 25	-5.87%
Jun 25	-6.02%
Jun 25	-6.56%
Jun 25	-6.09%
May 25	-7.21%
May 25	-8.12%
May 25	-7.92%
May 25	-7.78%
May 25	-6.98%
Apr 25	-7.19%
Apr 25	-7.58%
Apr 25	-8.1%
Apr 25	-7.08%
Mar 25	-6.11%
Mar 25	-5.68%
Mar 25	-6.17%
Mar 25	-5.88%
Feb 25	-5.26%
Feb 25	-5.13%
Feb 25	-5.37%
Feb 25	-4.9%
Jan 25	-4.61%
Jan 25	-4.48%
Jan 25	-9.31%
Jan 25	-9.26%
Jan 25	-7.55%
Dec 24	-9.94%
Dec 24	-9.38%
Dec 24	-9.24%
Dec 24	-9.29%
Nov 24	-8.01%
Nov 24	-8%
Nov 24	-8.13%
Nov 24	-7.22%
Nov 24	-6.49%
Oct 24	-6.7%
Oct 24	-5.87%

Price to Sales

NTRB Price to Sales by year
Period	Price to Sales
Sep 26	52.3
Sep 26	44.86
Aug 26	30.08
Aug 26	31.49
Aug 26	22.25
Aug 26	20.97
Jul 26	19.22
Jul 26	20.1
Jul 26	20.97
Jul 26	19.96
Jul 26	20.64
Jun 26	20.64
Jun 26	19.56
Jun 26	22.86
Jun 26	21.37
May 26	20.83
May 26	21.73
May 26	21.49
May 26	22.38
May 26	23.04
Apr 26	21.17
Apr 26	22.76
Apr 26	20.64
Apr 26	19.21
Mar 26	20.43
Mar 26	19.53
Mar 26	19.74
Mar 26	23.07
Feb 26	23.5
Feb 26	23.44
Feb 26	21.75
Feb 26	23.02
Jan 26	25.35
Jan 26	25.4
Jan 26	23.07
Jan 26	23.13
Jan 26	23.44
Dec 25	25.4
Dec 25	23.76
Dec 25	26.99
Dec 25	20.97
Nov 25	21.54
Nov 25	20.8
Nov 25	23.93
Nov 25	26.24
Oct 25	29.29
Oct 25	31.11
Oct 25	32.55
Oct 25	32.68
Oct 25	32.33
Sep 25	31.59
Sep 25	31.42
Sep 25	31.11
Sep 25	29.6
Aug 25	30.01
Aug 25	29.87
Aug 25	30.48
Aug 25	33.26
Aug 25	34.28
Jul 25	39.57
Jul 25	37.62
Jul 25	36.92
Jul 25	45.97
Jun 25	37.02
Jun 25	36.14
Jun 25	33.17
Jun 25	35.72
May 25	30.15
May 25	27.17
May 25	27.86
May 25	28.36
May 25	31.58
Apr 25	29.21
Apr 25	27.73
Apr 25	25.92
Apr 25	29.65
Mar 25	34.38
Mar 25	36.96
Mar 25	34.05
Mar 25	35.75
Feb 25	39.92
Feb 25	40.96
Feb 25	39.1
Feb 25	42.89
Jan 25	45.52
Jan 25	46.84
Jan 25	22.57
Jan 25	22.68
Jan 25	27.84
Dec 24	21.14
Dec 24	22.4
Dec 24	22.73
Dec 24	22.62
Nov 24	29.44
Nov 24	29.5
Nov 24	29.01
Nov 24	32.69
Nov 24	36.37
Oct 24	35.2
Oct 24	40.17

Price to Book

NTRB Price to Book by year
Period	Price to Book
Sep 26	15.88
Sep 26	13.62
Aug 26	9.05
Aug 26	9.48
Aug 26	6.7
Aug 26	6.31
Jul 26	5.78
Jul 26	6.05
Jul 26	6.31
Jul 26	6.01
Jul 26	6.21
Jun 26	6.21
Jun 26	5.89
Jun 26	6.88
Jun 26	6.52
May 26	6.35
May 26	6.62
May 26	6.55
May 26	6.82
May 26	7.02
Apr 26	6.39
Apr 26	6.87
Apr 26	6.23
Apr 26	5.8
Mar 26	6.17
Mar 26	5.89
Mar 26	5.96
Mar 26	6.96
Feb 26	7.09
Feb 26	7.08
Feb 26	6.56
Feb 26	6.95
Jan 26	7.65
Jan 26	7.67
Jan 26	6.96
Jan 26	6.98
Jan 26	7.08
Dec 25	7.67
Dec 25	7.17
Dec 25	8.15
Dec 25	6.37
Nov 25	6.54
Nov 25	6.31
Nov 25	7.26
Nov 25	7.96
Oct 25	8.89
Oct 25	9.44
Oct 25	9.88
Oct 25	9.92
Oct 25	9.81
Sep 25	9.59
Sep 25	9.54
Sep 25	9.44
Sep 25	13.91
Aug 25	14.11
Aug 25	14.04
Aug 25	14.32
Aug 25	15.63
Aug 25	16.11
Jul 25	18.6
Jul 25	17.68
Jul 25	17.35
Jul 25	21.61
Jun 25	17.4
Jun 25	16.98
Jun 25	15.59
Jun 25	16.79
May 25	14.17
May 25	9.04
May 25	9.27
May 25	9.44
May 25	10.51
Apr 25	5.26
Apr 25	4.99
Apr 25	4.67
Apr 25	5.34
Mar 25	6.19
Mar 25	6.65
Mar 25	6.13
Mar 25	6.43
Feb 25	7.19
Feb 25	7.37
Feb 25	7.04
Feb 25	7.72
Jan 25	8.19
Jan 25	8.43
Jan 25	4.06
Jan 25	4.08
Jan 25	5.01
Dec 24	3.81
Dec 24	4.03
Dec 24	4.09
Dec 24	4.07
Nov 24	4.26
Nov 24	4.27
Nov 24	4.2
Nov 24	4.73
Nov 24	5.26
Oct 24	5.1
Oct 24	5.81

No video analysis for this stock yet. Request one from our team.

News: NTRB

globenewswire.com · 9 Sep 2026

Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit

ORLANDO, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO, Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on September 16th.

globenewswire.com · 8 Sep 2026

Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch

Nutriband has received a Notice of Publication from the United States Patent and Trademark Office (USPTO) for commercial brand name trademarks for its lead product, an abuse deterrent fentanyl transdermal system. Once allowed, Nutriband plans to submit its commercial worldwide brand name to the FDA and other international regulatory agencies for approval.

globenewswire.com · 13 Aug 2026

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit on Aug 26th as part of the CEO spotlight event.